Your browser doesn't support javascript.
loading
Burden of allergic respiratory disease: a systematic review.
Linneberg, A; Dam Petersen, K; Hahn-Pedersen, J; Hammerby, E; Serup-Hansen, N; Boxall, N.
Afiliación
  • Linneberg A; Research Centre for Prevention and Health, The Capital Region of Denmark, Copenhagen, Denmark ; Department of Clinical Experimental Research, Rigshospitalet, Copenhagen, Denmark ; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Dam Petersen K; Department of Business and Management, Faculty of Social Sciences, Aalborg University, Aalborg, Denmark.
  • Hahn-Pedersen J; ALK, Hørsholm, Denmark.
  • Hammerby E; ALK, Hørsholm, Denmark.
  • Serup-Hansen N; ALK, Hørsholm, Denmark.
  • Boxall N; MAPI, London, UK.
Clin Mol Allergy ; 14: 12, 2016.
Article en En | MEDLINE | ID: mdl-27708552
This meta-analysis compared the health-related quality of life (HRQL) of patients with allergic rhinitis (AR) and/or allergic asthma (AA) caused by perennial house dust mite (HDM) versus AR and/or AA caused by seasonal pollen allergy. Following a systematic search, the identified studies used the disease-specific rhinitis quality of life questionnaire or generic instruments (SF-36 and SF-12). Summary estimates obtained by meta-analysis showed that HRQL in patients with perennial HDM allergy was significantly worse than that of patients with seasonal pollen allergy, when measured by both disease-specific and generic HRQL instruments, and was reflected by an impact on both physical and mental health. A systematic review of cost data on AR and AA in selected European countries demonstrated that the majority of the economic burden was indirectly caused by high levels of absenteeism and presenteeism; there was little or no evidence of increasing or decreasing cost trends. Increased awareness of the detrimental effects of AR and/or AA on patients' HRQL and its considerable cost burden might encourage early diagnosis and treatment, in order to minimize the disease burden and ensure beneficial and cost-effective outcomes.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Screening_studies / Systematic_reviews Aspecto: Patient_preference Idioma: En Revista: Clin Mol Allergy Año: 2016 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Screening_studies / Systematic_reviews Aspecto: Patient_preference Idioma: En Revista: Clin Mol Allergy Año: 2016 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Reino Unido